HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export business, with a "1+2+3+4=1" integrated service system and direct access to original FEP resin supplies from multiple well-known manufacturers.
As a foreign trade service provider with over a decade of market experience and long-term technical transformation cooperation with manufacturing plants, HiSiaddi possesses extensive expertise resolving product compliance issues. Below is a case study detailing HiSiaddi’s resolution of cross-border compliance challenges for FEP resins.
Please contact HiSiaddi customer service for further consultation on FEP resin compliance matters.
MedCable GmbH, headquartered in Munich Industrial Park, Bavaria, Germany, is a listed European leader specializing in minimally invasive medical interventional wires, high-temperature resistant special insulated cables for in-vitro diagnostic equipment and operating room medical devices, with over 40 years of expertise in medical fluoroplastic materials. Its products are supplied in bulk to Siemens Healthineers, Bayer Medical Consumables and public tertiary hospitals across Europe, functioning as a Tier 1 core supplier in the European medical cable sector. The company maintains stable annual FEP resin procurement volume of 360 tons, historically sourcing medical-grade FEP raw materials from Chemours (US) and Daikin (Japan). Its raw materials must adhere to five mandatory market access frameworks: EU REACH Regulation, POPs perfluorinated substance control legislation, CLP chemical labeling standards, ISO10993 medical biosafety criteria and German DIN medical material specifications, imposing far stricter compliance thresholds on PFAS residues in raw materials, chemical registration filings, compliant SDS documentation, export packaging labeling than general industrial goods. This represents a mid-to-high-end foreign client with dual stringent technical and compliance requirements.
In 2025, capacity constraints, price hikes and extended lead times (exceeding 120 days) for high-end grades from overseas fluorochemical manufacturers prompted MedCable’s procurement and compliance departments to launch a Chinese FEP localization substitution program. Following multi-round sample screening, a medical-grade FEP grade from a leading domestic fluorochemical manufacturer was preliminarily selected for an initial 80-ton purchase order scheduled for two sea shipments from Shanghai Port to Hamburg Port, Germany. On the eve of production completion and container loading, the client’s German compliance department issued an emergency audit alert identifying five critical non-compliance gaps in the domestic FEP product violating updated EU regulatory requirements covering PFAS perfluorinated residue control, REACH-SVHC filing, CLP-compliant SDS drafting, local German chemical notification and sea transport hazardous goods labeling. Direct shipment would result in cargo detention, seizure or forced destruction by German customs upon arrival at Hamburg Port, with estimated direct economic losses exceeding 180,000 EUR from detention, return transport and scrappage, alongside substantial liquidated damages for missed quarterly delivery deadlines to Siemens Healthineers.
The domestic original manufacturer solely focused on meeting physical property specifications and lacked operational capabilities for refined EU compliance management, only able to provide national standard Chinese test reports and simplified Chinese MSDS documents, unable to complete EU local compliance rectification. Referenced by local German chemical compliance institutions, MedCable issued an emergency mandate entrusting Shanghai HiSi Technology (HiSiaddi) with full accountability for end-to-end FEP product compliance rectification. Drawing on HiSiaddi’s multi-year global compliance resources for fluororesin foreign trade and dedicated in-house compliance engineering team, we systematically resolved the five compliance barriers, supplemented all required qualification documentation and secured smooth customs clearance and mass production delivery of the cargo.
Product Basic Information: FEP resin, CAS: 25067-58-7, HS Code: 3904690000, standard packaging: 25kg vacuum aluminum foil lined moisture-proof paper drums, grade: domestic medical transparent special FEP.
EU revised POPs Regulation (EU 2025/718) formally entered into force in July 2025, imposing strict limits on PFOA, PFOS and short-chain perfluorocarboxylic acid PFAS derivative residues within FEP raw materials. Medical-grade raw materials mandate PFOA monomer residual limit ≤25ppb and total short-chain PFAS derivative content ≤260ppb; materials exceeding these thresholds are prohibited from circulation, processing and medical end-use across the entire EU territory. The domestic original manufacturer only conducted basic component testing aligned with domestic chemical industry national standards, without targeted third-party testing for EU PFAS regulatory items. Spot check reports from accredited third-party laboratories revealed PFOA residues of 118ppb and total short-chain perfluorinated byproducts of 425ppb in the FEP batch, far exceeding EU medical raw material access thresholds – the primary fatal compliance risk flagged in the client’s audit alert. German customs implement a zero-tolerance random inspection mechanism for PFAS in medical fluoroplastic raw materials, with 100% detention of non-compliant cargo.
The domestic FEP grade only completed domestic chemical filing, lacking updated EU ECHA REACH pre-registration, full-component SVHC Substance of Very High Concern screening and mandatory entry into the EU SCIP waste material database per revised EU regulations. Under REACH Regulation, any fluoropolymer product exported to the EU in annual volumes exceeding 1 ton with SVHC substance content ≥0.1% detected must complete online SCIP notification; cargo without a valid SCIP notification number cannot be warehoused or processed within the EU market. The original manufacturer lacked dedicated REACH compliance staff and could not supply EU-recognized registration documentation, preventing the client’s German compliance audit team from completing supplier access filing, triggering automatic disqualification of raw material qualification within Siemens Healthineers’ incoming material audit system.
The original manufacturer only issued simplified Chinese MSDS documents drafted per domestic GB/T16483 standards, failing to comply with the latest EU CLP (EC 1272/2008) GHS framework for drafting bilingual German-English compliant SDS documents. Critical omissions included UFI unique chemical identification codes, hazard pictogram labeling, Exposure Scenario (ES) annexes and dedicated first-aid protocols for medical raw material exposure scenarios. Chemical component classification labeling adopted inconsistent standards vs. EU chemical classification catalogs. German Hamburg Port customs clearance mandates verification of CLP-compliant bilingual SDS documents, with non-compliant documentation triggering immediate rejection of customs declaration applications, and shipping lines refusing cargo booking due to non-compliant documentation.
Original outer packaging only printed Chinese product names, net weight and domestic manufacturer information, without bilingual German-English chemical safety labels aligned with local German GHS regulations. Missing mandatory elements included hazard storage-transport prompts, personal protective equipment guidance, importer registration information and waste disposal instructions, violating EU CLP packaging control regulations. Even if cargo cleared customs fortuitously, storage providers would refuse warehousing due to non-compliant packaging labeling.
Germany’s Chemical Control Regulation mandates completion of domestic chemical entry notification with the Federal Institute for Occupational Safety and Health (BAuA) prior to warehousing imported medical fluororesins to obtain a local German filing registration number. As a medical manufacturing enterprise, the client relies on this registration number to complete raw material warehousing filing and traceability documentation for downstream medical device products. The domestic manufacturer possessed no familiarity with local German notification procedures and lacked supporting compliance documentation.
HiSiaddi immediately coordinated SGS laboratories with EU-accredited testing qualifications to conduct full PFAS screening testing on sampled batches of the 80-ton FEP cargo. Root cause analysis identified insufficient temperature and vacuum parameters during post-polymerization devolatilization leading to incomplete removal of low-molecular PFOA and short-chain perfluorinated byproducts. HiSiaddi collaborated with upstream manufacturing partners to adjust production processes, reactivating three-stage stepped negative-pressure high-temperature devolatilization workflows (285℃, 298℃, 305℃ tiered vacuum stripping of low-molecular perfluorinated residues). After small-batch sample retesting confirmed compliance, the full 80-ton cargo batch was recalled to production facilities for secondary deep devolatilization treatment. Post-rectification, SGS issued EU-recognized English test reports confirming PFOA residues of 21ppb and total short-chain PFAS derivative content of 232ppb, fully within EU POPs medical raw material limit thresholds. HiSiaddi retained complete original testing chromatograms and sample submission ledgers for cross-reference during German customs random inspections and downstream incoming material audits by Siemens Healthineers.
Partnering with contracted local compliance firms based in Europe, HiSiaddi completed REACH compliance formalities in three sequential phases:
1. Leveraging HiSiaddi’s long-term fluororesin compliance resource library, existing REACH pre-registration files for the FEP grade were retrieved, with component information updated to align with 2025 revised EU regulatory standards and supplementary registration details provided for polymer monomers and additive ingredients;
2. Full-component SVHC Substance of Very High Concern screening was completed, issuing ECHA-recognized SVHC screening reports confirming no SVHC substances detected above threshold limits within the product;
3. Mandatory online filing was submitted to the EU SCIP waste material database for the full 80-ton shipment volume, generating an exclusive SCIP notification code integrated into the client’s German enterprise supply chain traceability system to satisfy Siemens Healthineers supplier access filing requirements. All REACH-related documentation was issued in official bilingual German-English versions, notarized and stamped by European compliance institutions.
HiSiaddi’s dedicated in-house compliance engineers collaborated with EU-certified chemical document drafters to discard original Chinese MSDS files and fully redevelop bilingual German-English 16-section compliant SDS safety data sheets aligned with the UN GHS Purple Book and latest EU CLP 9th edition standards. Supplementary content included UFI identification codes, dedicated exposure scenario annexes for medical application environments and emergency response protocols for fluororesin thermal decomposition. All chemical component classification labeling was fully benchmarked against official ECHA classification catalogs. Concurrently, bilingual German-English outer packaging safety labels were redesigned per local German GHS standards, incorporating hazard pictograms, storage-transport precautions and German importer registration information. The manufacturing facility was instructed to replace all outer and inner bag labels for the full 80-ton cargo batch to achieve traceable single-drum compliant labeling.
HiSiaddi contracted local compliance service providers based in Munich, Germany to submit FEP raw material entry notification applications to Germany’s Federal Institute for Occupational Safety and Health (BAuA) supported by full PFAS test reports, REACH registration documentation and compliant SDS files. An official local German chemical filing registration number was obtained within 12 working days, with filing information synchronized to Germany’s national chemical regulatory system. The client utilizes this registration number to complete medical raw material warehousing filing and full traceability documentation for finished medical devices, fully eliminating local German market access compliance barriers.
1. Domestic Customs Pre-Review: HiSiaddi’s customs declaration team conducted pre-classification audits under HS Code 3904690000, leveraging full compliance documentation, bilingual SDS and PFAS test reports to complete pre-inspection of export commodity inspection filings, standardizing domestic customs declaration elements to avoid domestic port detention due to incomplete documentation;
2. Sea Shipment Regulatory Filing: Compliant SDS documents and GHS label filing materials were submitted to shipping carriers to complete IMDG sea transport hazard classification pre-registration, enabling smooth cargo booking and loading;
3. Pre-emptive German Customs Clearance: Local cooperating customs brokers at Hamburg Port received full advance submission of all compliance qualification documentation and test reports for German customs pre-review, enabling expedited cargo inspection and release upon vessel arrival without detention warehousing or random inspection seizure risks.
Following full compliance rectification, the 80-ton FEP cargo was shipped in two batches from Shanghai Port to Hamburg Port, Germany. Upon arrival, German customs PFAS random testing and full compliance documentation verification yielded fully compliant results, enabling customs clearance and warehousing within 3 working days. MedCable’s Munich medical cable production line resumed full-capacity manufacturing, enabling on-time delivery of quarterly orders to Siemens Healthineers and eliminating potential direct losses of nearly 180,000 EUR stemming from cargo detention, scrappage and contract liquidated damages. The client’s German compliance department issued an official compliance evaluation report confirming HiSiaddi’s full-spectrum compliance solution meets all EU regulatory requirements, formalizing inclusion of the domestic FEP grade within the enterprise’s approved supplier list.
In Q4 2025, MedCable executed an annual FEP procurement framework agreement with HiSiaddi locking in 340 tons of annual medical-grade FEP purchase volume, entrusting HiSiaddi with end-to-end integrated services covering raw material selection, production quality control and full-spectrum cross-border compliance agency support. A dedicated compliance clause was appended to the procurement contract mandating HiSiaddi to proactively track evolving EU PFAS and REACH regulatory updates, conducting pre-compliance audits for all new production batches quarterly to eliminate future compliance risks at the source. Building on consistent compliant delivery performance, the client simultaneously initiated customized procurement demand for radiation-resistant aerospace medical special FEP grades, with HiSiaddi coordinating upstream manufacturing partners for sample development and pre-filing of compliance formalities in advance.
Leveraging this benchmark crisis resolution case with Germany’s leading medical enterprise, HiSiaddi capitalized on industry referral resources from MedCable to onboard three additional mid-to-high-end medical cable manufacturers in the Netherlands and Denmark. Standardized FEP compliance service models were replicated to deliver sample trials and small-batch orders, establishing differentiated compliance service barriers for HiSiaddi within the EU high-end medical fluororesin foreign trade niche – distinguishing our business model from traditional trading companies solely focused on physical goods delivery without crisis compliance resolution capabilities.
The core conflict driving this case stemmed from domestic fluororesin manufacturers prioritizing physical property compliance exclusively while neglecting refined localized EU regulatory details covering PFAS, REACH and CLP, exposing mid-to-high-end European medical clients to catastrophic operational risks including full cargo detention and order breach penalties. Breaking the traditional foreign trade model limited to raw material supply intermediation, HiSiaddi leverages global compliance resources and dedicated in-house compliance engineering teams to deliver closed-loop resolution of compliance challenges spanning raw material process rectification, third-party compliance testing, multi-jurisdictional qualification filing, documentation and packaging label optimization, and cross-border customs clearance support. The solution mitigated massive potential economic losses for the client while building deep long-term binding with high-end foreign end clients via value-added compliance services. Amid continuous tightening of global chemical environmental regulations, transitioning from pure commodity trade to integrated full-spectrum services combining products, technical support and global compliance solutions represents the core competitive path for chemical foreign trade enterprises to break free from homogeneous price competition and deepen penetration with overseas mid-to-high-end clients.
Please contact HiSiaddi customer service for further consultation on FEP resin compliance matters.
+86-13120989737 
info@hisiaddi.com 
English
